-55.8%
FIG vs GSK
+31.2%
-87.0%
-76.3%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | -4.4% | -1.9% | -2.4% | -4.5% |
| 7D | -16.3% | -1.8% | -14.5% | -16.5% |
| 30D | -14.3% | -2.2% | -12.1% | -14.6% |
| 3M | +7.2% | -1.8% | +9.0% | +7.0% |
| 6M | -18.6% | -10.6% | -8.0% | -18.7% |
| YTD | -35.5% | +4.4% | -39.9% | -37.0% |
| 1Y | -55.8% | +30.4% | -86.2% | -56.8% |
| All | -55.8% | +31.2% | -87.0% | -56.8% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling